Going further

Our team is driven by the desire to understand the human body. We believe there’s always something more to reveal, resulting in healthier, happier lives for us all.

Ashwin Pushpala
CEO
Ashwin Pushpala is the founder and CEO of Sano, the world’s first company to give people continuous and personalized insights into their body chemistry. Launching Sano five years ago, Ashwin hopes to see a world where everyone has access to their own biometric information, so they can make more thoughtful, proactive choices about their health. In 2017, he was named one of Forbes magazine’s “30 under 30” for his contributions in health and life sciences.

Ashwin was on the founding team of medical device company SinuSys after spending time at Bain Capital, where he invested in technology and semiconductor companies. Inspired by his parents’ work in the life science and semiconductor industries, Ashwin received a dual Bachelor’s degree in Bioengineering and Economics, and a Master’s in Bioengineering, from the University of Pennsylvania.
Abhijit Ghosh
VP, Software
Abhijit Ghosh is VP of Software at Sano, where he leads a multidisciplinary team of data science, signal processing, firmware, web services, infrastructure, and app development engineers. Abhijit is also one of the heaviest users of Sano’s CGM technology, having successfully used it to change his eating habits to lower his lipid levels and fasting blood glucose. Abhijit hopes to bring the same benefits he has experienced to the rest of the world, especially to pre-diabetics and people suffering from metabolic syndrome.

Abhijit has a Ph.D. in Computer Science from UC Berkeley, and has led engineering teams bringing new products to market at Stretch, Synopsys, Qvis, and Mitsubishi Electric Research.
Matthew Chapman
Director, R&D
Matthew Chapman is the Director of R&D at Sano, focusing on the development of Sano’s sensor technology. He lead a multidisciplinary team that uses electrochemistry, polymer chemistry, microfabrication, material science, and electrical engineering to develop and advance the capabilities of the platform. Matthew is excited about how access to real-time metabolic information will enable people to make better decisions—and drive discovery around human health and performance.

Matthew has an M.S. from the University of Chicago. Prior to joining Sano, he spent many years in academic research focusing on synthetic lipid membranes and protein interactions, super-resolution optical imaging, noninvasive prenatal diagnostics, and microfluidic technology at The University of Chicago, Baylor College of Medicine, and UC Berkeley.